Tortugas Neuroscience
Last verified 2026-06-13. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $106.0Mattributed |
|---|---|
| Latest round | series-a, $106.0M, 2026-04-21attributed |
| Founded | 2026 |
| Headquarters | Framingham, Massachusetts, USA |
| Industry | healthtech |
| Stage | series-a |
| Website | tortugasneuro.com |
Tortugas Neuroscience is a drug developer building a clinical pipeline for neurological and neuropsychiatric brain disorders, with four named assets. It targets patients with complex brain conditions that need new medicines. Its edge is a deliberate, patient-yet-purposeful development methodology grounded in research into the brain's complexity.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-21 | series-a | $106.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $106.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $106.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | tortugasneuro.com, read 2026-06-13 |
| Description | self-reported | tortugasneuro.com, read 2026-06-13 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.